Summary: Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on ‘Kennedy.’ Originally appearing here (Archived) …
Summary: In the Spring 2022 issue of the Harvard Medicinemagazine, Allison Eck weaves through the challenges of Harvard’s history with psychedelics to explore the current progress of interdisciplinary …
Summary: MAPS-sponsored researcher Rachel Yehuda, Ph.D., of Icahn School of Medicine at Mount Sinai joins PBS’ Healthy Minds with Dr. Jeffrey Borenstein of the Brain & Behavior Research Foundation …
Summary: Forbes publishes an exclusive report on the $500,000 donation to MAPS from atai Impact, the philanthropic arm of Berlin-based atai Life Sciences (NASDAQ: ATAI). Originally appearing here (Archived)
CBS News airs an investigative report about treating PTSD with MDMA-assisted therapy on a new episode of CBS Sunday Morning. In a series of interviews with David Martin of CBS, former Marine Scott Ostrom …
Summary: The New York Times publishes an investigative article exploring the impact of PTSD and moral injury in Veterans, highlighting published data from MAPS-sponsored clinical trials of MDMA-assisted …
The New York Times publishes an in-depth report on Veterans advancing the field of psychedelic medicine, highlighting personal experiences, public advocacy, drug policy reform efforts, and new initiatives …
Summary: Lindsay Robinson, Director of Development at MAPS, discusses how donations fund MAPS’ mission to catalyze psychedelic research, education, and policy reform. Originally appearing here (Archived)
The coming years could see a massive shift in the U.S. government’s approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental …
Psychedelics and inequality are inseparable for Bronner, 49. Drug policy reform, he believes, is integral to criminal justice reform. His company has donated more than $25 million since 2015 toward drug …
“Psychedelic-assisted therapies represent a potential new frontier in the treatment of mental health conditions, and our top priority is ensuring there is a path forward to integrate them into the health …
